Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02601313
Title A Phase 2 Multicenter Study Evaluating Subjects With Relapsed/Refractory Mantle Cell Lymphoma (ZUMA-2)
Acronym ZUMA-2
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kite Pharma, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | FRA | DEU


No variant requirements are available.